Xiaochen Wu

ORCID: 0009-0000-3733-3982
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Maritime Transport Emissions and Efficiency
  • Vehicle emissions and performance
  • Phonocardiography and Auscultation Techniques
  • BIM and Construction Integration
  • Power Systems and Technologies
  • Cardiomyopathy and Myosin Studies
  • Maritime Navigation and Safety
  • Diabetes Management and Research
  • Childhood Cancer Survivors' Quality of Life
  • Mechanical Circulatory Support Devices
  • Advanced battery technologies research
  • Sustainable Building Design and Assessment
  • Viral Infectious Diseases and Gene Expression in Insects
  • Family Support in Illness
  • Cardiovascular Health and Risk Factors
  • Maritime Ports and Logistics
  • Environmental Quality and Pollution
  • Economic Zones and Regional Development
  • Congenital Heart Disease Studies
  • Smart Grid and Power Systems
  • Cardiac Imaging and Diagnostics
  • Air Quality Monitoring and Forecasting
  • Cardiac Valve Diseases and Treatments

Zhejiang Hospital
2024

Soochow University
2024

Kao Yuan University
2024

Huangshan University
2024

Soochow University
2023-2024

Shanghai Children's Medical Center
2024

Shandong Jianzhu University
2024

Hainan Provincial Academy of Agricultural Sciences
2012-2023

Abstract Chimeric antigen receptor T-cell (CAR-T) therapy is effective in the treatment of relapsed/refractory acute B-lymphoblastic leukemia (R/R B-ALL); however, patients who receive CAR-T are predisposed to infections, with considerable detrimental effects on long-term survival rates and quality life patients. This study retrospectively analyzed infectious complications 79 pediatric R/R B-ALL treated cells at our institution. Overall, 53 developed 88 infections. Nine experienced nine...

10.1007/s10238-024-01339-7 article EN cc-by Clinical and Experimental Medicine 2024-04-25

Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment approach for pediatric patients suffering from relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, there was a paucity of data on challenges associated with second-round CAR-T in this population.Medical records nine who received single center June 2019 to May 2023 were analyzed. Throughout course clinical trial, we evaluated adverse events including CRS, CRES, infections, hematologic toxicity,...

10.1111/ejh.14092 article EN European Journal Of Haematology 2023-08-30

The ambient air quality standard (AAQS) is a vital policy instrument for protecting the environment and human health. Hainan Province at forefront of China's efforts to protect its ecological environment, with an official goal achieve world-leading by 2035. However, neither national AAQS nor World Health Organization guideline offers sufficient guidance improving in because has well met former while latter excessively stringent. Consequently, establishment Hainan's local becomes imperative....

10.1016/j.eehl.2023.10.002 article EN cc-by-nc-nd Eco-Environment & Health 2023-10-28

<title>Abstract</title> Chimeric antigen receptor T cell (CAR-T) therapy is effective in the treatment of relapsed/refractory acute B-lymphoblastic leukemia (R/R B-ALL); however, patients who receive CAR-T are predisposed to infections, with considerable detrimental effects on long-term survival rates and quality life patients. This study retrospectively analyzed infectious complications 79 pediatric R/R B-ALL treated cells at our institution. Overall, 53 developed 97 infections. Ten...

10.21203/rs.3.rs-3805105/v1 preprint EN cc-by Research Square (Research Square) 2024-01-02

Background Symptom distress and functional impairments in children with leukemia directly affect their quality of life. Objectives To identify subgroups symptom Chinese to examine the associations latent classes individual characteristics. Methods This multicenter cross-sectional survey study recruited who received chemotherapy 4 hospitals Shanghai, Jiangsu, Zhejiang, Guangdong Province. The participants were surveyed via PROMIS-25 (Patient-Reported Outcomes Measurement Information System...

10.1097/ncc.0000000000001422 article EN Cancer Nursing 2024-11-04
Coming Soon ...